$599 Million is the total value of RTW INVESTMENTS, LP's 32 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 22.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALNY | Sell | Alnylam Pharmaceuticals Inc | $45,582,000 | -37.8% | 358,774 | -42.4% | 7.61% | -40.4% |
| AVXS | Sell | Avexis Inc | $31,125,000 | -31.2% | 281,242 | -39.9% | 5.20% | -34.1% |
| ABUS | Sell | Arbutus Biopharma Corp | $26,016,000 | -20.3% | 5,151,615 | -2.2% | 4.34% | -23.6% |
| ATRA | Sell | Atara Biotherapeutics Inc | $10,066,000 | -7.3% | 556,118 | -15.2% | 1.68% | -11.2% |
| TCMD | Sell | Tactile Systems Technology Inc | $6,096,000 | -44.2% | 210,366 | -40.4% | 1.02% | -46.5% |
| OXFD | Sell | Oxford Immunotec Global PLC | $5,250,000 | -69.7% | 375,792 | -63.6% | 0.88% | -71.0% |
| SRTSW | Sell | SENSUS HEATLHCARE INC*w exp 06/08/201 | $98,000 | +8.9% | 151,400 | -2.3% | 0.02% | 0.0% |
| SBPH | Exit | Spring Bk Pharmaceuticals In | $0 | – | -249,095 | -100.0% | -0.73% | – |
| BLUE | Exit | bluebird bio Inc | $0 | – | -104,078 | -100.0% | -2.49% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2018-02-28
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS INC | 36 | Q3 2023 | 19.7% |
| MASIMO CORP | 32 | Q3 2023 | 5.8% |
| LA JOLLA PHARMACEUTICAL CO | 31 | Q2 2022 | 9.7% |
| REGENXBIO INC | 30 | Q4 2022 | 10.8% |
| AGENUS INC | 29 | Q2 2022 | 9.0% |
| PTC THERAPEUTICS INC | 28 | Q3 2023 | 12.8% |
| DICERNA PHARMACEUTICALS INC | 28 | Q3 2021 | 10.8% |
| MIRATI THERAPEUTICS INC | 26 | Q3 2023 | 6.2% |
| ARGENX SE | 26 | Q3 2023 | 5.3% |
| VERICEL CORP | 24 | Q3 2023 | 3.9% |
View RTW INVESTMENTS, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | September 19, 2023 | 18,188,457 | - |
| ALLURION TECHNOLOGIES, INC. | August 11, 2023 | 3,457,707 | 7.4% |
| Orchestra BioMed Holdings, Inc. | May 05, 2023 | 5,620,645 | 15.7% |
| Renovacor, Inc.Sold out | April 05, 2023 | 0 | - |
| Adverum Biotechnologies, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Aptevo Therapeutics Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ASLAN Pharmaceuticals LtdSold out | February 14, 2023 | 0 | 0.0% |
| Athira Pharma, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| BELLUS Health Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Clearside Biomedical, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
View RTW INVESTMENTS, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-03-01 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View RTW INVESTMENTS, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.